Florida Society of Interventional Pain Physicians
Florida Society of Interventional Pain Physicians
Florida Society of Interventional Pain Physicians

Welcome to

Florida Society of Interventional Pain Physicians

 

FSIPP is THE voice for interventional pain physicians.


FSIPP has been a leader in promoting fair legislation, access to care and protecting reimbursement. We continue to educate payors, state officials and organizations regarding our area of expertise. We must take ownership of our speciality, promote well developed research and continue to expand our mission in the public and political arena.

Our Mission

To promote the development and practice of safe, high quality, cost-effective interventional pain management techniques for the diagnosis and treatment of pain and related disorders, and to ensure patient access to interventional pain medicine (or management) doctors and these treatments in the State of Florida.


Events


Conference Schedule

  • Friday May 20

    8:00–8:05 AM
    Crystal Ballroom G1(A&B)
    Welcome Address
    Harold L. Dalton, DO – FSIPP President

    8:05–8:30 AM
    Crystal Ballroom G1(A&B)
    Interventional Pain Management for Headaches
    Andrea Trescot, MD - FSIPP Past President, Director at Large and Founding Member, Past President ASIPP

    8:30–9:00 AM
    Crystal Ballroom G1(A&B)
    Pelvic Pain
    Andrea Trescot, MD - FSIPP Past President, Director at Large and Founding Member, Past President ASIPP

    9:00–9:20 AM
    Crystal Ballroom G1(A&B)
    Update On Sterile, Nonsterile And Topical Compounding Options For Pain
    Ken Speidel, PharmD

    9:20–9:40 AM
    Crystal Ballroom G1(A&B)
    Buprenorphine: Pain v. Addiction
    Miguel de la Garza, MD, FSIPP Director at Large

    9:40–10:00 AM
    Crystal Ballroom G1(A&B)
    Office Based Surgery
    Deborah Tracy, MD – FSIPP Secretary

    10:00–10:30 AM
    Salon H
    Break with Exhibits and Poster Viewing

    10:30–10:50 AM
    Crystal Ballroom G1(A&B)
    Vertebral Augmentation
    Deborah Tracy, MD – FSIPP Secretary

    10:50 –11:20 AM
    Crystal Ballroom G1(A&B)
    Update on CRPS
    Steve Stanos, MD

    11:20–11:45 PM
    Crystal Ballroom G1(A&B)
    Sacroiliac Joint Pain
    Jonathan Daitch, MD, MBA – FSIPP Treasurer

    11:45–12:15 PM
    Crystal Ballroom G1(A&B)
    Radiofrequency Pearls – Expanding your Pain Practice
    Richard Epter, MD

    12:15–1:15 PM
    Crystal C-G2
    Industry Sponsored Luncheon Symposium
    Sponsored by St. Jude - Neuromodulation
    New Advancements in Neuromodulation

    Robert Levy, MD, PhD
    *No CME credit hours available for this session

    1:15-3:00 PM
    Crystal Ballroom G1(A&B)
    Regenerative Medicine

    1:15–1:45 PM
    Crystal Ballroom G1(A&B)
    The History and Future of Stromal Vascular Fraction (SVF)
    Mark Berman, MD, FACS

    1:45–2:30 PM
    Crystal Ballroom G1(A&B)
    The Science Behind Fat and Bone Marrow Derived Stem Cells
    Orlando Florete, MD – FSIPP President Elect

    2:30–3:15 PM
    Crystal Ballroom G1(A&B)
    A2M, An Alternative to Steroids
    Guy Scuderi, MD

    3:15–3:45 PM
    Salon H
    Break with Exhibits and Poster Viewing

    Crystal D&E
    Product Theater - Sponsored by Xenoport
    Horizant (Gabapentin Enacarbil) - A thoughtfully engineered transported prodrug technology to support predictable absorption and dose proportional bioavailability

    Steven Simon, MD
    *This session is not eligible for CME credit hours


    Regenerative Medicine Continued

    3:40–4:15 PM
    Crystal Ballroom G1(A&B)
    The FDA and Stromal Vascular Fraction (SVF)
    Elliot Lander, MD, FACS

    4:15–5:00 PM
    Crystal Ballroom G1(A&B)
    Putting it all Together - where does PRP fit in a Pain Practice? And session Q&A
    Panel - All Faculty from Regenerative Medicine Sessions

    5:30–6:30 PM
    Salon H
    Cocktail hour with Exhibits

    6:30-8:30 PM
    Crystal C-G2
    Featured Performer – Ronin Taiko
    Silent Auction

    7:30-9:30 PM
    Industry Sponsored Dine Arounds
    Sponsored by Platinum and Gold Sponsors
    Pre-registration required

  • Saturday May 21

    7:30–8:00 AM
    Salon H
    Continental Breakfast

    8:00-8:05 AM
    Crystal Ballroom G1(A&B)
    Welcome and Housekeeping
    Harold L. Dalton, DO – FSIPP President

    8:05–8:30 AM
    Crystal Ballroom G1(A&B)
    IPM Guidelines
    Laximiah Manchikanti, MD – CEO ASIPP

    8:30–8:50 AM
    Crystal Ballroom G1(A&B)
    The True Cost of Not Treating Pain Patients
    Porter McRoberts, MD

    8:50–9:10 AM
    Crystal Ballroom G1(A&B)
    A DEA Perspective on Controlled Substance Use and Abuse
    Susan Langston, DPM, Office of Diversion Control, DEA

    9:10-9:30 AM
    Crystal Ballroom G1(A&B)
    Checking the Financial Pulse of your Practice – Reports and Things to Watch out for
    Harold Cordner, MD – ASIPP Secretary, FSIPP Past President and Director at Large

    9:30–10:00 AM
    Salon H
    Break with Exhibits with Poster Viewing

    Crystal D & E
    Product Theater – sponsored by Pfizer
    One Prescription Opioid’s Journey

    Mario Mendoza, MD, MS, Medical Director US Medical Affairs, Pain Medicines Pfizer Inc
    Dr. Mendoza formerly worked for the FDA and as an Anesthesiologist for the NIH
    *This session is not eligible for CME credit hours

    10:00-10:45 AM
    Crystal Ballroom G1(A&B)
    Compliance and Coding Changes (including ICD-10) for Pain Management in 2016
    David Vaughn, Esq.

    10:45-11:05 AM
    Crystal Ballroom G1(A&B)
    Interdisciplinary Approach to Pelvic Pain – Case Studies
    Cynthia Neville, DPT

    11:05–11:25 AM
    Crystal Ballroom G1(A&B)
    Pain Clinic Regulation--How effective has it been?
    Lucy Gee

    11:25–11:45 AM
    Crystal Ballroom G1(A&B)
    Integration of Manipulative Treatment in Interventional Medicine
    Joel Stein, DO

    11:45-12:05 PM
    Crystal Ballroom G1(A&B)
    MILD Study Results
    Ramsin Benyamin, MD

    12:05–12:30 PM
    Crystal Ballroom G1(A&B)
    Psychiatric Co-Morbidities in Chronic Pain
    Rafael Miguel, MD – FSIPP Director at Large

    12:30–1:30 PM
    Crystal C-G2
    Industry Sponsored Luncheon Symposium
    Hf10™ Therapy: Developed Through Best-In-Class Clinical Evidence
    Sponsored by Nevro – Gold Sponsor

    Porter McRoberts, MD
    Rick Bundschu, MD
    *No CME credit hours available for this session

    1:30–2:00 PM
    Crystal Ballroom G1(A&B)
    Utilization and Efficacy of Botox in the Treatment of Chronic Pain
    Jesse Lipnick, MD – FSIPP Vice President

    2:00–2:30 PM
    Crystal Ballroom G1(A&B)
    Opioid Hyperalgesia, Fact or Fiction?
    Sanford Silverman, MD – FSIPP Past President

    2:30–2:50 PM
    Crystal Ballroom G1(A&B)
    Post Herpetic Neuralgias
    Maulik Bhalani, MD – FSIPP Director at Large

    2:50–3:10 PM
    Crystal Ballroom G1(A&B)
    Radiation Safety
    Ron DeMeo, MD

    3:10-3:30 PM
    Crystal Ballroom G1(A&B)
    The Past, Present and Future of Neuromodulation and Interventional Pain Management
    Richard Epter, MD

    3:30–4:00PM
    Salon H
    Break with Exhibits and Poster Viewing

    Crystal D

    4:00–4:20 PM
    Crystal Ballroom G1(A&B)
    National State of the Union Address on Interventional Pain Management
    Peter Staats, MD, MBA – ASIPP President

    4:20–4:40 PM
    Crystal Ballroom G1(A&B)
    Florida State of Union Address on Interventional Pain Management
    Jon Johnson, Esq., Partner, Johnson & Blanton

    4:40–5:00 PM
    Crystal Ballroom G1(A&B)
    Putting it in Perspective for Florida
    Harold L. Dalton, DO - FSIPP President

    5:00–6:30 PM
    Crystal Ballroom G1(A&B)
    State Society Meeting
    PAC Fundraiser

    6:30–7:30 PM
    Crystal C-G2
    Industry Sponsored Dinner Symposium
    Sponsored by Medtronic – Gold Sponsor

    *No CME credit hours available for this session

    7:30–9:00 PM
    Faculty Cocktail Reception - By Invitation Only

  • Saturday May 21 - Safe Controlled Substance Management Course

    Safe Controlled Substance Management Course
    Crystal C-G2


    7:30–8:00 AM
    Salon H
    Continental Breakfast

    8:00-8:05 AM
    Welcome and Housekeeping
    Sanford Silverman, MD FSIPP Past President
    Concurrent Session Course Director

    8:05–8:30 AM
    Terminology and Neurobiology of Addiction
    Sanford Silverman, MD FSIPP Past President
    Concurrent Session Course Director

    8:30–8:50 AM
    Pharmacology of Opioids and Sedatives/Hypnotics
    Jonathan Daitch, MD

    8:50–9:10 AM
    Cannabinoids and Pain
    Orlando Florete, MD

    9:10-9:30 AM
    Abuse Deterrent Formulations and Overdose Prevention
    Anand Thakur, MD

    9:30–10:00 AM
    Salon H
    Break with Exhibits and Poster Viewing

    Crystal D & E
    Product Theater – sponsored by Pfizer
    One Prescription Opioid’s Journey

    Mario Mendoza, MD, MS, Medical Director US Medical Affairs, Pain Medicines Pfizer Inc
    Dr. Mendoza formerly worked for the FDA and as an Anesthesiologist for the NIH
    *This session is not eligible for CME credit hours

    10:00-10:30 AM
    Defending your Practice and Responding to a Controlled Substance Investigation
    Harold Cordner, MD - ASIPP Secretary, FSIPP Past President and Director at Large

    10:30-11:00 AM
    Dealing with the Difficult and Manipulative Patient
    Hans Hansen, MD

    11:00–11:30 AM
    CDC Guidelines: Potential Impact On Pain Management.
    Sanford Silverman, MD FSIPP Past President
    Concurrent Session Course Director

    11:30–12:00 PM
    Management of Withdrawal and Exit Strategies with Controlled Substances
    Sanford Silverman, MD FSIPP Past President
    Concurrent Session Course Director

    12:00–12:15 PM
    Proper Prescribing of Controlled Substances in Florida
    Deborah Tracy, MD – FSIPP Secretary

    12:15-12:30 PM
    Interactive panel discussion and Q & A

    12:30–1:30 PM
    Crystal D & E
    Industry Sponsored Luncheon Symposium
    Abuse Deterrent Technologies
    Sponsored by Purdue Pharma – Gold Sponsor

    Dr. Martin Hale
    *No CME credit hours available for this session

  • Saturday May 21 - Business of Pain

    The Business of Pain Program
    Crystal C-G2


    1:30–1:35 PM
    Welcome and Housekeeping
    Orlando Florete, MD, FSIPP President Elect and
    Jonathan Daitch, MD, FSIPP Treasurer - Concurrent Session Course Directors

    1:35–2:05 PM
    Better Talent, Better Business: Using Strategic Recruitment Methods to Hire and Retain Top Talent
    Nicola Hawkinson, CEO Spine Search

    2:05–2:25 PM
    Your Online Professional Profile and Rating – How GOOD Patients Evaluate Physicians and What You Can Do to Improve Your Rating
    Rich Devine, Review Concierge

    2:25–2:45 PM
    Urine Toxicology, DNA Testing and Other Ancillary Revenue Sources: What is real, what is legal, what do you need to know?
    Jonathan Daitch, MD, MBA – FSIPP Treasurer

    2:45-3:10 PM
    OIG-Recovery Audit Contractor (RAC) Audits
    David Vaughn, Esp.

    3:10-3:30 PM
    Coding Changes in 2016 and Beyond
    Marvel Hammer, RN

    3:30–4:00 PM
    Salon H
    Break with Exhibits and Poster Viewing

    4:00–4:45 PM
    ICD-10
    Laxamiah Manchikanti, MD – CEO ASIPP

    4:45–5:00 PM
    ICD-10 Q&A
    Laxamiah Manchikanti, MD – CEO ASIPP

    5:00 PM
    Crystal Ballroom G1(A&B)
    Sessions Close

  • Sunday May 22

    7:30–8:00 AM
    Salon H
    Continental Breakfast

    8:00–8:30 AM
    Crystal Ballroom G1(A&B)
    Intrathecal Pain Management, New Pumps, New Drugs, New Protocols?
    Jason Pope, MD

    8:30–9:00 AM
    Crystal Ballroom G1(A&B)
    Advances in Neurostimulation
    Harold Cordner, MD, Robert Levy, MD,

    9:00–9:20 AM
    Crystal Ballroom G1(A&B)
    HF10 Therapy Overview
    Richard Bundschu, MD

    9:20-9:40 AM
    Crystal Ballroom G1(A&B)
    High Frequency Nerve Block- the Science and Applications
    Porter McRoberts, MD

    9:40-10:00 AM
    Crystal Ballroom G1(A&B)
    Panel Discussion
    Richard Bundschu, MD, Harold Cordner, MD, Robert Levy, MD, PhD, Porter McRoberts, MD

    10:00–10:30 AM
    Salon H
    Break with Exhibits

    10:30 – 12:30 PM
    Crystal Ballroom G1(A&B)
    Patient Safety and Complication Management
    Moderator: Harold Cordner, MD – ASIPP Secretary and FSIPP Past President and Director at Large

    10:30–10:50 AM
    Crystal Ballroom G1(A&B)
    Rare Complications of SCS
    Rasmin Beny AMin, MD

    10:50–11:20 AM
    Crystal Ballroom G1(A&B)
    Infection Control in Implantable Devices: Understanding Current Practices
    Ken Candido, MD

    11:20-11:40 AM
    Crystal Ballroom G1(A&B)
    Patient Selection with SCS – Who, What, Where and Why
    Lou Raso, MD

    11:40-12:00 PM
    Crystal Ballroom G1(A&B)
    Epidural Steroid Injection Therapy – Efficacy, Frequency and Reimbursement
    Moderator: Steven Cohen, MD
    Panel: Larry Dalton, DO and Ken Candido, M

    12:00-12:30 PM
    Top 3 winning poster presentations
    Moderator: Jonathan Daitch, MD

    12:30-1:00 PM
    Q & A

    1:00 PM
    Meeting Adjourns

  • Sunday May 22 - Ultrasound Course

    Ultrasound Course


    1:30–4:00 PM
    Crystal C-G2

    1:30-2:00 PM
    Crystal C-G2
    Anatomy and Physiology with Ultrasound
    Karina Gritsenko, MD

    2:00–2:30 PM
    Utilization of Ultrasound in IPM – Intrathecal Pump Refills, Injections
    Stanley Golovac, MD

    2:30–4:00 PM
    Hands on rotations (live models)
    1) Head and neck injections
    2) Shoulder and upper extremities
    3) Low back and Hip
    4) Knee and lower extremities

    Stanley Golovac, MD
    Karina Gritsenko, MD
    Alex Martinez, MD


 

Latest News & Alerts

March 23, 2016

FDA Drug Safety Communication: FDA warns about several safety issues with opioid pain medicines; requires label changes

Safety Announcement

The U.S. Food and Drug Administration (FDA) is warning about several safety issues with the entire class of opioid pain medicines. These safety risks are potentially harmful interactions with numerous other medications, problems with the adrenal glands, and decreased sex hormone levels. We are requiring changes to the labels of all opioid drugs to warn about these risks.

Read the Entire Alert Here


February 25, 2016

REGARDING: MEANINGFUL USE ATTESTATION

MGMA is recommending that all physicians, healthcare facility groups and hospitals apply for the meaningful use hardship exception. The reason being, is that even if you have already attested, we have no idea how CMS will handle these attestations, as they were so late in clarifying the measures. Additionally, some of you are counting on your EHR or registry to successfully submit your data, which may not happen. This will not prevent you from a bonus if your attestation is successful and you are in a bonus category. But if anything goes wrong it will prevent you from a 3% cut on all Medicare claims in 2019. The deadline for submitting the hardship extension is March 15, 2016.

SELECT 2.2d AS THE REASON FOR THE HARDSHIP APPLICATION.

Click Here for the application.


FSIPP in the News:

Bills, FDA Can Help Deter Abuse of Prescription Opioids

Harold Cordner, MD

The use of opioids to treat acute and chronic nonmalignant and malignant pain has steadily increased since the late 1990s. With this increase in opioid use, prescription opioid abuse increased to epidemic proportions. In 2012, an estimated 2.1 million Americans suffered through substance-abuse problems related to prescription opioid pain relievers. Florida was the epicenter of prescription-drug abuse, overdose deaths and "pill mills."

Since 2010, the state of Florida has drastically reduced the accidental deaths due to prescription opioid abuse through legislation, the enactment of the Prescription Drug Monitoring Program, the crackdown on pill mills and other means.

Read the entire article here


DEA Reacts to Accusations Made at Pharmacy Board Hearing

FSIPP President Harold L Dalton, DO in attendance.


DEERFIELD BEACH, Fla. —Fear of the DEA has been a recurring theme in the WESH 2 News ongoing investigation of Florida's prescription drug problem. Patients with real health issues are being denied the medication.

The DEA said it would answer those accusations at Florida's Board of Pharmacy hearing Monday.

"We don't want people to fear us, ...

Read the entire article and see the news cast video here.

 

Thank You to Our Current Sponsors

 

 

Aegis

 

 

 

 

 

 

 

 

 

 

 

corp sponsor

 

Enjoy the many benefits of becoming an FSIPP Corporate Sponsor. Great exposure with a high-quality organization. Click here to read more.

Diamond Sponsors

Platinum Sponsors

Gold Sponsors

Gold Sponsors

 


President's Circle

Reserved for those who donate to the FSIPP PAC or to FSIPP.

See who is in the club…


Associations

Pain Truth Our parent organization is ASIPP, the American Society of Interventional Pain Physicians. Visit ASIPPs website, for a bountiful resource for pain practitioners, and to review a list of ASIPPs accomplishments which have greatly benefited both pain patients and pain physicians.

 

FSPMRFlorida Society of Physical Medicine and Rehabilitation ... enhancing Health And Function Through Education And Research In The Field Of Physical Medicine And Rehabilitation.

Read their latest Newsletter